Opportunity, I know you would like to see Moro begin clinical trials leading to an FDA submission for approval.
It appears that Moro has indeed changed his mind about doing the approval process and is now planning on relying on the licensees for that function.
I certainly see both your position and Moro's position.
Your advice would use up the current funds more quickly. The Taglich report stated Moro had current funding until mid 2011. That is just 8 months away.
Beginning clinical trials would indeed raise the stock price. I don't know for how long but investors always react to good news. If the share price remained higher, even though additional funds were needed earlier, they might be placed at a higher price. Right now, I doubt Moro could place many share until he lowered the price to less than 5 cents.
The time to accomplish monitoring trials as Moro cited at the ISOBM would indeed require following patients over a period of time. This is going to greatly extend the period needed before FDA submission and even then, the FDA is always a wild card and they may not approve the product.
It is a huge risk of money for Moro and both you and I know that RECAF or any other product would not be successful with self marketing by a company with little or no money. There has to be an active licensee. Neither Abbott nor Alere appear to be advancing so Moro may indeed just want to hang on to his money as long as possible in an attempt to either get Dog RECAF selling or to sign another licensee.
Unfortunately, everyone should realize that without Abbott and Alere showing progress, the likelyhood of some other licensee signing is remote.
Look at what Burger stated about Abbott. He was going to attempt a meeting to get them moving or terminate them. It looks like neither option happened and I doubt Abbott would even talk to him.
News 
Market Data 
Discover 
